Chemoinformaics analysis of 3,4,4-Trimethylheptadec-2-EN-2-OL
| Molecular Weight | 410.683 | nRot | 23 |
| Heavy Atom Molecular Weight | 360.283 | nRig | 6 |
| Exact Molecular Weight | 410.376 | nRing | 0 |
| Solubility: LogS | -1.707 | nHRing | 0 |
| Solubility: LogP | 2.253 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 79.1656 |
| nHD | 0 | BPOL | 53.6324 |
| QED | 0.688 |
| Synth | 2.975 |
| Natural Product Likeliness | -0.599 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.308 |
| MDCK | 0.0000337 |
| BBB | 0.941 |
| PPB | 0.551976 |
| VDSS | 1.291 |
| FU | 0.343799 |
| CYP1A2-inh | 0.634 |
| CYP1A2-sub | 0.869 |
| CYP2c19-inh | 0.201 |
| CYP2c19-sub | 0.91 |
| CYP2c9-inh | 0.058 |
| CYP2c9-sub | 0.711 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.689 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.491 |
| CL | 6.606 |
| T12 | 0.487 |
| hERG | 0.016 |
| Ames | 0.109 |
| ROA | 0.711 |
| SkinSen | 0.709 |
| Carcinogencity | 0.486 |
| EI | 0.862 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.062 |
| Antiviral | No |
| Prediction | 0.562727 |